Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Yuval Cohen is recorded as CEO and Board Member at Corbus Pharmaceuticals Holdings, Inc. (CRBP). Corbus Pharmaceuticals Holdings, Inc. reported in an 8-K filed May 20, 2024 that Yuval Cohen was appointed director, effective May 16, 2024. The proxy statement of Corbus Pharmaceuticals Holdings, Inc. reports total compensation of $3,750,125 for Yuval Cohen in fiscal 2025, including a base salary of $646,566. Disclosed compensation is on record for 5 fiscal years. Yuval Cohen has spoken on 4 earnings calls and 2 other investor events across 1 company, most recently for Corbus Pharmaceuticals Holdings, Inc. on June 4, 2026.
“The election of each of Yuval Cohen, Alan Holmer, Avery W. Catlin, Rachelle Jacques, John Jenkins, Peter Salzmann, Anne Altmeyer and Yong Ben as directors to hold office for a term of one year, until his or her successor is duly elected and qualified or he or she is otherwise unable to complete his or her term.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Recorded current and former roles; source labels appear when available.
2014-01-01–present
Start not stated–present
Recorded roles and call appearances connecting this person to public companies.
CEO, Board Member
2014-01-01–present
Other people whose current roles at this company are on record from its filings.
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Chief Executive Officer | $646,566 | $3,750,125 |
| 2024 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Chief Executive Officer | $621,883 | $4,245,438 |
| 2023 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Chief Executive Officer | $598,850 | $1,137,622 |
| 2022 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Chief Executive Officer | $598,071 | $1,442,841 |
| 2021 | Corbus Pharmaceuticals Holdings, Inc. (CRBP) | Chief Executive Officer | $578,675 | $4,858,306 |
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.
